• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Cadre Holdings Inc.

    2/14/22 5:12:28 PM ET
    $CDRE
    Industrial Specialties
    Health Care
    Get the next $CDRE alert in real time by email
    SC 13G 1 tm225842d2_sc13g.htm SC 13G

     

     

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D. C. 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

     

     

    cadre holdings, inc.

    (Name of Issuer)

     

     

    Common Stock, $0.0001 Par Value

    (Title and Class of Securities)

     

    12763L105 

    (CUSIP Number)

     

    December 31, 2021

    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this schedule is filed:

     

    x Rule 13d-1(b)

    ¨ Rule 13d-1(c)

    ¨ Rule 13d-1(d)

     

     

     

     

     

     

    CUSIP No. 12763L105   Page 2 of 12 Pages

     

    1

    NAMES OF REPORTING PERSONS
    S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS

     

    WYNNEFIELD PARTNERS SMALL CAP VALUE, L.P. 13-3688497

     

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨
    (b) x Reporting Person is affiliated with other persons

     

     

    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5

    SOLE VOTING POWER

     

    540,338 Shares

     

    6

    SHARED VOTING POWER

     

    0

     

    7

    SOLE DISPOSITIVE POWER

     

    540,338 Shares

     

    8

    SHARED DISPOSITIVE POWER

     

    0

     

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    540,338 Shares

     

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ¨

     

     
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    1.6%

     

    12

    TYPE OF REPORTING PERSON

     

    PN

     

             

     

     2 

     

     

    CUSIP No. 12763L105   Page 3 of 12 Pages

     

    1

    NAMES OF REPORTING PERSONS
    S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS

     

    WYNNEFIELD PARTNERS SMALL CAP VALUE, L.P. I 13-3953291

     

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨
    (b) x Reporting Person is affiliated with other persons

     
    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5

    SOLE VOTING POWER

     

    1,016,343 Shares

     

    6

    SHARED VOTING POWER

     

    0

     

    7

    SOLE DISPOSITIVE POWER

     

    1,016,343 Shares

     

    8

    SHARED DISPOSITIVE POWER

     

    0

     

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,016,343 Shares

     

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ¨

     

     
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    3.0%

     

    12

    TYPE OF REPORTING PERSON

     

    PN

     

             

     

     3 

     

     

    CUSIP No. 12763L105   Page 4 of 12 Pages

     

    1

    NAMES OF REPORTING PERSONS
    S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS

     

    WYNNEFIELD SMALL CAP VALUE OFFSHORE FUND, LTD. (No IRS Identification No.)

     

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨
    (b) x Reporting Person is affiliated with other persons

     
    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Cayman Islands

     

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5

    SOLE VOTING POWER

     

    236,629 Shares

     

    6

    SHARED VOTING POWER

     

    0

     

    7

    SOLE DISPOSITIVE POWER

     

    236,629 Shares

     

    8

    SHARED DISPOSITIVE POWER

     

    0

     

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    236,629 Shares

     

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ¨

     

     
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.7%

     

    12

    TYPE OF REPORTING PERSON

     

    CO

     

             

     

     4 

     

     

    CUSIP No. 12763L105   Page 5 of 12 Pages

     

    1

    NAMES OF REPORTING PERSONS
    S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS

     

    WYNNEFIELD CAPITAL MANAGEMENT, LLC 13-4018186

     

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨
    (b) x Reporting Person is affiliated with other persons

     
    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    New York

     

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5

    SOLE VOTING POWER

     

    1,556,681 Shares (1)

     

    6

    SHARED VOTING POWER

     

    0

     

    7

    SOLE DISPOSITIVE POWER

     

    1,556,681 Shares (1)

     

    8

    SHARED DISPOSITIVE POWER

     

    0

     

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,556,681 Shares (1)

     

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ¨

     

     
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    4.6% (1)

     

    12

    TYPE OF REPORTING PERSON

     

    OO

     

             

    (1) Wynnefield Capital Management, LLC holds an indirect beneficial interest in these shares which are directly beneficially owned by Wynnefield Partners Small Cap Value, L.P. and Wynnefield Partners Small Cap Value, L.P. I.

     

     5 

     

     

    CUSIP No. 12763L105   Page 6 of 12 Pages

     

    1

    NAMES OF REPORTING PERSONS
    S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS

     

    WYNNEFIELD CAPITAL, INC. 13-3688495

     

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨
    (b) x Reporting Person is affiliated with other persons

     

     

    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5

    SOLE VOTING POWER

     

    236,629 Shares (1)

     

    6

    SHARED VOTING POWER

     

    0

     

    7

    SOLE DISPOSITIVE POWER

     

    236,629 Shares (1)

     

    8

    SHARED DISPOSITIVE POWER

     

    0

     

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    236,629 Shares (1)

     

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ¨

     

     
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.7% (1)

     

    12

    TYPE OF REPORTING PERSON

     

    CO

     

             

    (1) Wynnefield Capital, Inc. holds an indirect beneficial interest in these shares which are directly beneficially owned by Wynnefield Small Cap Value Offshore Fund, Ltd.

     

     6 

     

     

    CUSIP No. 12763L105   Page 7 of 12 Pages

      

    1

    NAMES OF REPORTING PERSONS
    S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS

     

    NELSON OBUS

     

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨
    (b) x Reporting Person is affiliated with other persons

     

     

    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5

    SOLE VOTING POWER

     

    1,793,310 Shares (1)

     

    6

    SHARED VOTING POWER

     

    0

     

    7

    SOLE DISPOSITIVE POWER

     

    1,793,310 Shares (1)

     

    8

    SHARED DISPOSITIVE POWER

     

    0

     

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,793,310 Shares (1)

     

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ¨

     

     
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    5.2% (1)

     

    12

    TYPE OF REPORTING PERSON

     

    IN

     

             

    (1) Mr. Obus may be deemed to hold an indirect beneficial interest in these shares, which are directly beneficially owned by Wynnefield Partners Small Cap Value, L.P., Wynnefield Partners Small Cap Value, L.P. I and Wynnefield Small Cap Value Offshore Fund, Ltd. because he is a co-managing member of Wynnefield Capital Management, LLC, a principal executive officer of Wynnefield Capital, Inc. (the investment manager of Wynnefield Small Cap Value Offshore Fund, Ltd.). The filing of this Statement and any future amendment by Mr. Obus, and the inclusion of information herein and therein with respect to Mr. Obus, shall not be considered an admission that he, for the purpose of Section 16(b) of the Exchange Act, is the beneficial owner of any shares in which he does not have a pecuniary interest. Mr. Obus disclaims any beneficial ownership of the shares of Common Stock covered by this Statement.

     

     7 

     

     

    CUSIP No. 12763L105   Page 8 of 12 Pages

     

    1

    NAMES OF REPORTING PERSONS
    S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS

     

    JoSHUA Landes

     

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨
    (b) x Reporting Person is affiliated with other persons

     
    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5

    SOLE VOTING POWER

     

    1,793,310 Shares (1)

     

    6

    SHARED VOTING POWER

     

    0

     

    7

    SOLE DISPOSITIVE POWER

     

    1,793,310 Shares (1)

     

    8

    SHARED DISPOSITIVE POWER

     

    0

     

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,793,310 Shares (1)

     

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ¨

     

     
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    5.2% (1)

     

    12

    TYPE OF REPORTING PERSON

     

    IN

     

             

    (1) Mr. Landes may be deemed to hold an indirect beneficial interest in these shares, which are directly beneficially owned by Wynnefield Partners Small Cap Value, L.P., Wynnefield Partners Small Cap Value, L.P. I and Wynnefield Small Cap Value Offshore Fund, Ltd. because he is a co-managing member of Wynnefield Capital Management, LLC, a principal executive officer of Wynnefield Capital, Inc. (the investment manager of Wynnefield Small Cap Value Offshore Fund, Ltd.). The filing of this Statement and any future amendment by Mr. Landes, and the inclusion of information herein and therein with respect to Mr. Landes, shall not be considered an admission that he, for the purpose of Section 16(b) of the Exchange Act, is the beneficial owner of any shares in which he does not have a pecuniary interest. Mr. Landes disclaims any beneficial ownership of the shares of Common Stock covered by this Statement.

     

     8 

     

     

    CUSIP No. 12763L105   Page 9 of 12 Pages

     

    Item 1(a).

    Name of Issuer:

     

    Cadre Holdings, Inc.

     

    Item 1(b).

    Address of Issuer's Principal Executive Offices:

     

    13386 International Pkwy, Jacksonville, Florida 32218

     

    Item 2(a).

    Name of Person Filing:

     

        Wynnefield Partners Small Cap Value, L.P. (“Partners”)  
        Wynnefield Partners Small Cap Value, L.P. I (“Partners I”)  
        Wynnefield Small Cap Value Offshore Fund, Ltd. (“Fund”)  
        Wynnefield Capital Management, LLC (“WCM”)  
        Wynnefield Capital, Inc. (“WCI”)  
        Nelson Obus  
        Joshua Landes  
           
    Item 2(b).

    Address of Principal Business Office or, if None, Residence:

     

    450 Seventh Avenue, Suite 509, New York, New York 10123

     

    Item 2(c).

    Citizenship:

     

        Partners and Partners I are Delaware limited partnerships.  
        Fund is Cayman Islands company.  
        WCM is a New York limited liability company.  
        WCI is a Delaware corporation.  
        Mr. Obus and Mr. Landes are United States citizens.  

     

     9 

     

     

    CUSIP No. 12763L105   Page 10 of 12 Pages

     

    Item 2(d).

    Title of Class of Securities:

     

    Common Stock, $0.0001 Par Value Per Share.

     

    Item 2(e).

    CUSIP Number:

     

    12763L105

     

    Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
    (a) ¨ Broker or Dealer registered under Section 15 of the Act.
    (b) ¨ Bank as defined in Section 3(a)(6) of the Act.
    (c) ¨ Insurance Company as defined in Section 3(a)(19) of the Act.
    (d) ¨ Investment Company registered under Section 8 of the Investment Company Act.
    (e) x Investment Adviser registered in accordance with Rule 13d-1(b)(1)(ii)(E).
    (f) ¨ Employee Benefit Plan or Endowment Fund in accordance with Rule 13d-1(b)(1)(ii)(F).
    (g) ¨ Parent Holding Company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).
    (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.
    (i) ¨

    A church plan that is excluded from the definition of an investment company under Section 3(c) (14) of the Investment Company Act of 1940.

    (j) ¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
        If this Statement is filed pursuant to Rule 13d-1(c), check this box  ¨ .

     

     10 

     

     

    CUSIP No. 12763L105   Page 11 of 12 Pages

     

    Item 4.

    Ownership.

     

    (a)       Amount beneficially owned: 1,793,310 Shares

     

    (b)       Percent of Class: 5.2% of Common Stock

     

    (c)       Number of Shares as to which the person has:

     

    (i)         Sole power to vote or to direct the vote: 1,793,310 Shares

     

    (ii)        Shared power to vote or to direct the vote: 0 Shares

     

    (iii)       Sole power to dispose or to direct the disposition of: 1,793,310 Shares

     

    (iv)       Shared Power to dispose or to direct the disposition of: 0 Shares

     

    Item 5. Ownership of Five Percent or Less of a Class.
       
      If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. ¨.
       
    Item 6

    Ownership of More than Five Percent on Behalf of Another Person.

     

    Not Applicable.

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

     

    Not Applicable.

     

    Item 8.

    Identification and Classification of Members of the Group.

     

    See Item 2(a)-(c).

     

    Item 9.

    Notice of Dissolution of Group.

     

    Not Applicable.

     

    Item 10.

    Certifications.

     

    By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     11 

     

     

    CUSIP No. 12763L105   Page 12 of 12 Pages

     

    SIGNATURE

     

    Date: February 14, 2022  WYNNEFIELD PARTNERS SMALL CAP VALUE, L.P.
        
       By: Wynnefield Capital Management, LLC, General Partner
        
         By: /s/ Nelson Obus
           Nelson Obus, Managing Member
        
       WYNNEFIELD PARTNERS SMALL CAP VALUE, L.P. I
        
       By: Wynnefield Capital Management, LLC, General Partner
        
         By: /s/ Nelson Obus
           Nelson Obus, Managing Member
        
       WYNNEFIELD SMALL CAP VALUE OFFSHORE FUND, LTD.
        
       By: Wynnefield Capital, Inc.
        
         By: /s/ Nelson Obus
           Nelson Obus, President
        
       WYNNEFIELD CAPITAL MANAGEMENT, LLC
        
         By: /s/ Nelson Obus
           Nelson Obus, Co-Managing Member
        
       WYNNEFIELD CAPITAL, INC.
        
         By: /s/ Nelson Obus
           Nelson Obus, President
        
       /s/ Nelson Obus
       Nelson Obus, Individually
        
       /s/ Joshua Landes
       Joshua Landes, Individually

     

     12 

     

    Get the next $CDRE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CDRE

    DatePrice TargetRatingAnalyst
    2/21/2024$32.00 → $38.00Buy
    ROTH MKM
    1/22/2024Outperform → Mkt Perform
    Raymond James
    9/6/2022$30.00Buy
    BofA Securities
    8/31/2022$32.00Buy
    Jefferies
    3/11/2022$25.00 → $27.00Outperform
    Raymond James
    11/29/2021$24.00Buy
    Lake Street
    11/29/2021$23.00Overweight
    Stephens
    11/29/2021$20.00Hold
    Stifel
    More analyst ratings

    $CDRE
    Financials

    Live finance-specific insights

    See more
    • Cadre Holdings Reports First Quarter 2025 Financial Results

      Capitalizes on Continued Strong Demand for Mission Critical Safety Equipment Completes Acquisition of Multiple Leading Nuclear Brands, Expanding Geographic Footprint Increased Guidance Reflects Completed Acquisition and Reaffirmed Organic Growth Expectations 2025 Outlook: Net Sales of $618 to $648 Million and Adjusted EBITDA of $112 to $122 Million Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three months ended March 31, 2025. Net sales of $130.

      5/6/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Announces First Quarter 2025 Earnings and Conference Call Information

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the first quarter that ended on March 31, 2025, on Tuesday, May 6, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, May 7, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To participate in

      4/23/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Declares Quarterly Dividend of $0.095 Per Share

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis. Cadre's dividend payment will be made on May 16, 2025 to shareholders of record as of the close of business on the record date of May 2, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors. About Cadre Headquartered in Jacksonville, Florida, Cadre is a globa

      4/22/25 4:16:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    Leadership Updates

    Live Leadership Updates

    See more
    • Cadre Holdings Appoints Gianmaria Delzanno to its Board of Directors

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced the appointment of Gianmaria Delzanno to its board of directors, effective as of January 13, 2025. Current Director Nicholas Sokolow, who joined the board of Cadre's predecessor in July of 2012, will retire from the Company's board, effective as of January 31, 2025. Upon Mr. Sokolow's departure, Mr. Delzanno will replace Mr. Sokolow as the lead independent director and will also serve as Chairman of the Nominating and Corporate Governance Committee as

      1/13/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Appoints Deborah DeCotis to its Board of Directors

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety and survivability equipment for first responders, announced the appointment of Deborah DeCotis to its board of directors, effective immediately. With Ms. DeCotis' appointment, the Board will expand to five directors, four of whom are independent. Ms. DeCotis will also serve on the Company's Compensation Committee. Ms. DeCotis has over 45 years of financial, advisory and business operations experience with a successful track record of leadership across multiple global institutions and industries. She currently serves as Advisory Director at Morgan Stanley & Co., Inc.

      4/12/22 8:30:00 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • ElectraMeccanica Appoints Automotive Veteran, William Quigley III, to Board of Directors

      VANCOUVER, British Columbia, April 07, 2022 (GLOBE NEWSWIRE) -- ElectraMeccanica Vehicles Corp. (NASDAQ:SOLO) ("ElectraMeccanica" or the "Company"), a designer and manufacturer of electric vehicles revolutionizing the urban driving experience, today announced the appointment of William (Bill) Quigley III to its Board of Directors. Mr. Quigley is an accomplished leader with a proven track record in large enterprises specific to the automotive industry. With 30 plus years in the industry, Bill's career has included the following key roles: Executive Vice President and Chief Financial Officer at Dana Holding Corporation, an automotive, commercial vehicle and off-highway driveline, sealing an

      4/7/22 8:05:00 AM ET
      $CDRE
      $SOLO
      Industrial Specialties
      Health Care
      Auto Manufacturing
      Consumer Discretionary

    $CDRE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cadre Holdings Reports First Quarter 2025 Financial Results

      Capitalizes on Continued Strong Demand for Mission Critical Safety Equipment Completes Acquisition of Multiple Leading Nuclear Brands, Expanding Geographic Footprint Increased Guidance Reflects Completed Acquisition and Reaffirmed Organic Growth Expectations 2025 Outlook: Net Sales of $618 to $648 Million and Adjusted EBITDA of $112 to $122 Million Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three months ended March 31, 2025. Net sales of $130.

      5/6/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Announces First Quarter 2025 Earnings and Conference Call Information

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the first quarter that ended on March 31, 2025, on Tuesday, May 6, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, May 7, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To participate in

      4/23/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Declares Quarterly Dividend of $0.095 Per Share

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis. Cadre's dividend payment will be made on May 16, 2025 to shareholders of record as of the close of business on the record date of May 2, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors. About Cadre Headquartered in Jacksonville, Florida, Cadre is a globa

      4/22/25 4:16:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Cadre Holdings Inc.

      SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

      11/12/24 9:50:14 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • SEC Form SC 13G filed by Cadre Holdings Inc.

      SC 13G - Cadre Holdings, Inc. (0001860543) (Subject)

      2/14/24 7:58:49 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • SEC Form SC 13G/A filed by Cadre Holdings Inc. (Amendment)

      SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

      2/12/24 4:15:31 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    SEC Filings

    See more
    • SEC Form 10-Q filed by Cadre Holdings Inc.

      10-Q - Cadre Holdings, Inc. (0001860543) (Filer)

      5/6/25 4:17:42 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Cadre Holdings, Inc. (0001860543) (Filer)

      5/6/25 4:15:16 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Cadre Holdings Inc.

      SCHEDULE 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

      4/29/25 4:15:29 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • ROTH MKM reiterated coverage on Cadre Holdings with a new price target

      ROTH MKM reiterated coverage of Cadre Holdings with a rating of Buy and set a new price target of $38.00 from $32.00 previously

      2/21/24 9:51:23 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings downgraded by Raymond James

      Raymond James downgraded Cadre Holdings from Outperform to Mkt Perform

      1/22/24 7:15:32 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • BofA Securities initiated coverage on Cadre Holdings with a new price target

      BofA Securities initiated coverage of Cadre Holdings with a rating of Buy and set a new price target of $30.00

      9/6/22 7:24:20 AM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: SEC Form 4 filed by CHIEF FINANCIAL OFFICER Browers Blaine

      4/A - Cadre Holdings, Inc. (0001860543) (Issuer)

      4/24/25 4:47:07 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Amendment: SEC Form 4 filed by PRESIDENT Williams Brad

      4/A - Cadre Holdings, Inc. (0001860543) (Issuer)

      4/24/25 4:45:45 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Amendment: SEC Form 4 filed by CEO AND CHAIRMAN Kanders Warren B

      4/A - Cadre Holdings, Inc. (0001860543) (Issuer)

      4/24/25 4:45:13 PM ET
      $CDRE
      Industrial Specialties
      Health Care